Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
February 05, 2026
Pricey whole-body MRIs don’t add up
For cancer screening, proven methods tailored to an individual’s risk level make more sense
TakePART-NW, an ambitious new precision oncology research program, launches at Fred Hutch
Patients who opt in may help solve the mysteries of cancer and other diseases
Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo
Fred Hutch laboratory research presented at the American Society of Gene and Cell Therapy’s annual meeting moves a promising approach one step closer to clinical trials
New hope for people with colorectal cancer that has spread to the liver
Fred Hutch is the only center in Washington state offering high-dose chemotherapy through hepatic artery infusion
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
Substituting cyclophosphamide for a standard post-transplant immunosuppressant is a “gamechanger”
Surprising findings about blood cell mutations bode well for transplant recipients
Fred Hutch researchers compared blood samples from 16 recipient-donor pairs, some more than 45 years after transplant
Fred Hutch receives funding to advance Indigenous cancer health equity
Cooperative agreement will support work on smoking cessation, lung cancer screening, patient navigation and more
Fred Hutch Phase 1 Program director, Dr. John Thompson, retires
An immunotherapy champion, Thompson co-led the melanoma clinic for decades
Employee-engagement survey delivers welcome news
Fred Hutch employees report they feel valued, including on DEI issues
For Fred Hutch biostatisticians, numbers are no game
Meticulous work at the SWOG Statistics and Data Management Center, housed at Fred Hutch, may alter care for bladder cancer and lymphoma
Fred Hutch Science Education Partnership receives $1.35M grant
The award will support new programming for students and teachers on health inequities
Volunteer patient advocate can’t help helping others
For this podcaster, breast cancer patient and self-described “clinical trials fanatic,” advocacy starts with community building
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
10 Washington groups take on cancer health disparities with grants from Fred Hutch
Community Grants Program funds projects statewide to improve cancer outcomes and build organizational capacity
Novel chemoimmunotherapy approach shows promise for B-cell acute lymphoblastic leukemia in phase 1 study at Fred Hutch
DA-EPOCH plus inotuzumab ozogamicin was “safe and highly active” in adults with relapsed or refractory disease
Dr. Bart Scott named Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair
Chair recognizes a quarter-century of commitment to advancing MDS treatment and the opportunities ahead
‘If you want to go far, go together’
Fred Hutch scientist Dr. Jennifer Adair partners with colleagues around the globe to make gene therapies more effective and more widely available
Multiple myeloma research to be presented at American Society of Hematology annual meeting
Dr. Rahul Banerjee to share insights on reducing financial toxicity, time toxicity and side effects of treatment
Dr. Lawrence Fong to lead Immunotherapy Integrated Research Center
International expert will help scale up Fred Hutch’s clinical expertise in solid tumor immunotherapy
Dr. Hans-Peter Kiem awarded amfAR grant for research on HIV gene therapy
Potential cure builds on unexpected findings about hematopoietic stem cells